

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muscle activity (GO:0014850) | 3.88557469 |
| 2 | actin-mediated cell contraction (GO:0070252) | 3.71590674 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.70913758 |
| 4 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.69051695 |
| 5 | carnitine shuttle (GO:0006853) | 3.63440946 |
| 6 | lysine catabolic process (GO:0006554) | 3.63141716 |
| 7 | lysine metabolic process (GO:0006553) | 3.63141716 |
| 8 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.56824123 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 3.54888329 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.54732489 |
| 11 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53514483 |
| 12 | synaptic vesicle maturation (GO:0016188) | 3.53417238 |
| 13 | fatty acid transmembrane transport (GO:1902001) | 3.44404486 |
| 14 | aspartate family amino acid catabolic process (GO:0009068) | 3.44298666 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.37853027 |
| 16 | plasma membrane repair (GO:0001778) | 3.34639899 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.33884290 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31537810 |
| 19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.30019444 |
| 20 | * regulation of synaptic vesicle transport (GO:1902803) | 3.29203655 |
| 21 | cell communication by electrical coupling (GO:0010644) | 3.26638485 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.24394953 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.20243105 |
| 24 | succinate metabolic process (GO:0006105) | 3.19589749 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.18753408 |
| 26 | locomotory exploration behavior (GO:0035641) | 3.16179290 |
| 27 | sodium ion export (GO:0071436) | 3.16164667 |
| 28 | cell communication involved in cardiac conduction (GO:0086065) | 3.12299578 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11575512 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.09288528 |
| 31 | potassium ion import (GO:0010107) | 3.09111702 |
| 32 | cardiac muscle contraction (GO:0060048) | 3.08243467 |
| 33 | sarcomere organization (GO:0045214) | 3.06817269 |
| 34 | regulation of relaxation of muscle (GO:1901077) | 3.06147162 |
| 35 | NADH metabolic process (GO:0006734) | 3.05127145 |
| 36 | cerebellar granule cell differentiation (GO:0021707) | 3.02141471 |
| 37 | skeletal muscle contraction (GO:0003009) | 2.99887420 |
| 38 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.99245993 |
| 39 | cGMP-mediated signaling (GO:0019934) | 2.99103838 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 2.98715001 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 2.98645560 |
| 42 | actin filament-based movement (GO:0030048) | 2.97781364 |
| 43 | neuronal action potential propagation (GO:0019227) | 2.97226624 |
| 44 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.96290204 |
| 45 | carnitine transmembrane transport (GO:1902603) | 2.96196804 |
| 46 | activation of protein kinase A activity (GO:0034199) | 2.96083780 |
| 47 | positive regulation of synapse maturation (GO:0090129) | 2.95859725 |
| 48 | regulation of membrane repolarization (GO:0060306) | 2.95334726 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 2.94468846 |
| 50 | carnitine transport (GO:0015879) | 2.93207074 |
| 51 | amino-acid betaine transport (GO:0015838) | 2.93207074 |
| 52 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.92797352 |
| 53 | alpha-linolenic acid metabolic process (GO:0036109) | 2.91085333 |
| 54 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.90058181 |
| 55 | neuronal ion channel clustering (GO:0045161) | 2.88931726 |
| 56 | muscle filament sliding (GO:0030049) | 2.88183773 |
| 57 | actin-myosin filament sliding (GO:0033275) | 2.88183773 |
| 58 | short-chain fatty acid metabolic process (GO:0046459) | 2.87835189 |
| 59 | L-amino acid import (GO:0043092) | 2.87709482 |
| 60 | dicarboxylic acid catabolic process (GO:0043649) | 2.87558079 |
| 61 | striated muscle hypertrophy (GO:0014897) | 2.86316209 |
| 62 | response to mercury ion (GO:0046689) | 2.86060980 |
| 63 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.84803396 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 2.84207639 |
| 65 | regulation of skeletal muscle contraction (GO:0014819) | 2.84075511 |
| 66 | muscle cell cellular homeostasis (GO:0046716) | 2.83981049 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.83053734 |
| 68 | L-phenylalanine catabolic process (GO:0006559) | 2.83053734 |
| 69 | creatine metabolic process (GO:0006600) | 2.80515250 |
| 70 | L-phenylalanine metabolic process (GO:0006558) | 2.80263158 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.80263158 |
| 72 | skeletal muscle fiber development (GO:0048741) | 2.79728555 |
| 73 | glutamate secretion (GO:0014047) | 2.79394523 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 2.77795976 |
| 75 | potassium ion homeostasis (GO:0055075) | 2.77031198 |
| 76 | glutamate metabolic process (GO:0006536) | 2.76427096 |
| 77 | cardiac myofibril assembly (GO:0055003) | 2.75756480 |
| 78 | muscle contraction (GO:0006936) | 2.75487940 |
| 79 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.75200850 |
| 80 | regulation of fatty acid oxidation (GO:0046320) | 2.73853902 |
| 81 | oxaloacetate metabolic process (GO:0006107) | 2.73670817 |
| 82 | relaxation of smooth muscle (GO:0044557) | 2.73629331 |
| 83 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72871054 |
| 84 | cellular response to epinephrine stimulus (GO:0071872) | 2.72780220 |
| 85 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.72669750 |
| 86 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.72669750 |
| 87 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.72447208 |
| 88 | vocalization behavior (GO:0071625) | 2.72033534 |
| 89 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70756801 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.70536348 |
| 91 | striated muscle contraction (GO:0006941) | 2.69229359 |
| 92 | axon ensheathment in central nervous system (GO:0032291) | 2.68736801 |
| 93 | central nervous system myelination (GO:0022010) | 2.68736801 |
| 94 | relaxation of muscle (GO:0090075) | 2.68238109 |
| 95 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67444598 |
| 96 | glycogen catabolic process (GO:0005980) | 2.66941173 |
| 97 | neurotransmitter secretion (GO:0007269) | 2.66346467 |
| 98 | regulation of ARF protein signal transduction (GO:0032012) | 2.65632641 |
| 99 | myofibril assembly (GO:0030239) | 2.65493524 |
| 100 | tricarboxylic acid metabolic process (GO:0072350) | 2.63937998 |
| 101 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.63839048 |
| 102 | cardiac muscle adaptation (GO:0014887) | 2.63407335 |
| 103 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.63407335 |
| 104 | muscle hypertrophy in response to stress (GO:0003299) | 2.63407335 |
| 105 | amino acid import (GO:0043090) | 2.63101004 |
| 106 | detection of calcium ion (GO:0005513) | 2.62720506 |
| 107 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.61177845 |
| 108 | ADP metabolic process (GO:0046031) | 2.61023570 |
| 109 | synaptic vesicle exocytosis (GO:0016079) | 2.60705678 |
| 110 | fatty acid catabolic process (GO:0009062) | 2.60589592 |
| 111 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.60015391 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 2.59859762 |
| 113 | neuromuscular synaptic transmission (GO:0007274) | 2.59132678 |
| 114 | neuromuscular process controlling balance (GO:0050885) | 2.58234397 |
| 115 | gamma-aminobutyric acid transport (GO:0015812) | 2.57840490 |
| 116 | muscle system process (GO:0003012) | 2.57500876 |
| 117 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.57406337 |
| 118 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.56323536 |
| 119 | regulation of synapse maturation (GO:0090128) | 2.55487120 |
| 120 | muscle hypertrophy (GO:0014896) | 2.55184623 |
| 121 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.54680299 |
| 122 | fatty acid oxidation (GO:0019395) | 2.54255216 |
| 123 | exploration behavior (GO:0035640) | 2.53703861 |
| 124 | regulation of actin filament-based movement (GO:1903115) | 2.53280626 |
| 125 | glyoxylate metabolic process (GO:0046487) | 2.52395758 |
| 126 | glucan catabolic process (GO:0009251) | 2.52250854 |
| 127 | lipid oxidation (GO:0034440) | 2.51557609 |
| 128 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.51117708 |
| 129 | ketone body metabolic process (GO:1902224) | 2.50955695 |
| 130 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.50865173 |
| 131 | quaternary ammonium group transport (GO:0015697) | 2.49951713 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 2.49271263 |
| 133 | glycine transport (GO:0015816) | 2.47503123 |
| 134 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.47426934 |
| 135 | monocarboxylic acid catabolic process (GO:0072329) | 2.47393310 |
| 136 | regulation of cofactor metabolic process (GO:0051193) | 2.46179453 |
| 137 | regulation of coenzyme metabolic process (GO:0051196) | 2.46179453 |
| 138 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.45617600 |
| 139 | kynurenine metabolic process (GO:0070189) | 2.44492186 |
| 140 | cellular sodium ion homeostasis (GO:0006883) | 2.43857882 |
| 141 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.43673515 |
| 142 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43145174 |
| 143 | membrane depolarization during action potential (GO:0086010) | 2.43111185 |
| 144 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.42654910 |
| 145 | cellular response to catecholamine stimulus (GO:0071870) | 2.42531628 |
| 146 | cellular response to monoamine stimulus (GO:0071868) | 2.42531628 |
| 147 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.41936586 |
| 148 | response to epinephrine (GO:0071871) | 2.40903418 |
| 149 | regulation of synaptic plasticity (GO:0048167) | 2.39212468 |
| 150 | postsynaptic membrane organization (GO:0001941) | 2.38596796 |
| 151 | cellular response to cadmium ion (GO:0071276) | 2.37916067 |
| 152 | actomyosin structure organization (GO:0031032) | 2.36172332 |
| 153 | myotube cell development (GO:0014904) | 2.35301580 |
| 154 | barbed-end actin filament capping (GO:0051016) | 2.35298809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.80978822 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60164481 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54238014 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69219202 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60706302 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.44241694 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29798674 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26581849 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19072655 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.17701636 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.08190553 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07133886 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02409144 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95488922 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94635976 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.94133862 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91860789 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90442705 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86805402 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86805402 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69227501 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67808569 |
| 23 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67487355 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67311787 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63686207 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63154087 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.58757323 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57641631 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56026458 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55504317 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54469797 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53339545 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53190806 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52933220 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50000339 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47291725 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42664597 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39469281 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39214114 |
| 40 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38109325 |
| 41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.34336366 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31540129 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31253093 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30585666 |
| 45 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.30461076 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.30461076 |
| 47 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.27327867 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24172415 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23149234 |
| 50 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.23011435 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22075269 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17540709 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14525138 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14325625 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13051413 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12668646 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12644356 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11524991 |
| 59 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11125152 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07320414 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07161525 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05488113 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04239773 |
| 64 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03074198 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02859257 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01659732 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01570244 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01243675 |
| 69 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01115281 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01052413 |
| 71 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00760360 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00422037 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98738024 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98586458 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97685782 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97333561 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97083396 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97080751 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96845339 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95502193 |
| 81 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95430734 |
| 82 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95316770 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95042905 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94384503 |
| 85 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94068555 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93978766 |
| 87 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93023746 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92780061 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92380843 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92379770 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91284544 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91007260 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90837239 |
| 94 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89829689 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89769201 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89507667 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89217882 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88949195 |
| 99 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88042405 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88038345 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86601529 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86254217 |
| 103 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.86188658 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83656739 |
| 105 | AR_19668381_ChIP-Seq_PC3_Human | 0.83415890 |
| 106 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83248386 |
| 107 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83127011 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80649056 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 0.80513055 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78261029 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77650654 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76776942 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76682710 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75842267 |
| 115 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75224195 |
| 116 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75220611 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75204474 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72934427 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.72640576 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.72590444 |
| 121 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72048059 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.72035513 |
| 123 | SA1_27219007_Chip-Seq_Bcells_Human | 0.71730502 |
| 124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.71642328 |
| 125 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.70994785 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.70874800 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70694186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.07385854 |
| 2 | MP0003646_muscle_fatigue | 3.75424716 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.60909936 |
| 4 | MP0000751_myopathy | 3.60244553 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.79903158 |
| 6 | MP0004130_abnormal_muscle_cell | 2.73946310 |
| 7 | MP0002822_catalepsy | 2.65318118 |
| 8 | MP0005360_urolithiasis | 2.63700579 |
| 9 | MP0000749_muscle_degeneration | 2.54209714 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.51410944 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.45757516 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.40791626 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.33227686 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.30173489 |
| 15 | * MP0003635_abnormal_synaptic_transmissio | 2.11754866 |
| 16 | MP0004270_analgesia | 2.09056534 |
| 17 | MP0005365_abnormal_bile_salt | 2.06936346 |
| 18 | MP0000747_muscle_weakness | 1.98791358 |
| 19 | MP0005330_cardiomyopathy | 1.95522579 |
| 20 | MP0005451_abnormal_body_composition | 1.90675509 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.89293815 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.86044373 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74569810 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.74341051 |
| 25 | MP0009745_abnormal_behavioral_response | 1.72544648 |
| 26 | MP0003329_amyloid_beta_deposits | 1.70747755 |
| 27 | MP0002269_muscular_atrophy | 1.69720300 |
| 28 | MP0003880_abnormal_central_pattern | 1.68072821 |
| 29 | MP0002064_seizures | 1.64001971 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.62324044 |
| 31 | MP0004043_abnormal_pH_regulation | 1.60219016 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.57242559 |
| 33 | MP0008004_abnormal_stomach_pH | 1.55891275 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.55024343 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.52281545 |
| 36 | MP0009046_muscle_twitch | 1.52247200 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.52154750 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.50797538 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.50536868 |
| 40 | MP0005083_abnormal_biliary_tract | 1.48448670 |
| 41 | MP0005332_abnormal_amino_acid | 1.47682105 |
| 42 | MP0004484_altered_response_of | 1.45482281 |
| 43 | MP0000920_abnormal_myelination | 1.41957773 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.41509409 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.38869075 |
| 46 | MP0008569_lethality_at_weaning | 1.38801564 |
| 47 | MP0009840_abnormal_foam_cell | 1.37688119 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.36261261 |
| 49 | MP0005535_abnormal_body_temperature | 1.35055657 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.33593935 |
| 51 | MP0004085_abnormal_heartbeat | 1.32536538 |
| 52 | * MP0006036_abnormal_mitochondrial_physio | 1.32522851 |
| 53 | MP0003195_calcinosis | 1.31662596 |
| 54 | MP0003252_abnormal_bile_duct | 1.31633425 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.30834909 |
| 56 | * MP0002272_abnormal_nervous_system | 1.29329172 |
| 57 | MP0005369_muscle_phenotype | 1.28407004 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.28143280 |
| 59 | MP0004233_abnormal_muscle_weight | 1.26629633 |
| 60 | MP0003045_fibrosis | 1.26177380 |
| 61 | MP0004858_abnormal_nervous_system | 1.24484179 |
| 62 | MP0008775_abnormal_heart_ventricle | 1.23928383 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.22687343 |
| 64 | MP0002108_abnormal_muscle_morphology | 1.21714788 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21203047 |
| 66 | MP0000750_abnormal_muscle_regeneration | 1.18724321 |
| 67 | MP0005385_cardiovascular_system_phenoty | 1.17769210 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 1.17769210 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.16241406 |
| 70 | MP0001486_abnormal_startle_reflex | 1.15874819 |
| 71 | MP0005166_decreased_susceptibility_to | 1.14614716 |
| 72 | MP0003690_abnormal_glial_cell | 1.13952756 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.12278946 |
| 74 | MP0005670_abnormal_white_adipose | 1.12196305 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.12057987 |
| 76 | MP0000733_abnormal_muscle_development | 1.11361413 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 1.10568168 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.10452409 |
| 79 | MP0006138_congestive_heart_failure | 1.10263305 |
| 80 | MP0003075_altered_response_to | 1.08947387 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.05260396 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.05225326 |
| 83 | MP0005409_darkened_coat_color | 1.03838120 |
| 84 | * MP0003633_abnormal_nervous_system | 1.03051720 |
| 85 | MP0001958_emphysema | 1.02800372 |
| 86 | MP0002971_abnormal_brown_adipose | 1.01862984 |
| 87 | MP0000604_amyloidosis | 1.01721088 |
| 88 | MP0005375_adipose_tissue_phenotype | 1.01332627 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.01308243 |
| 90 | MP0010630_abnormal_cardiac_muscle | 1.01096655 |
| 91 | MP0003634_abnormal_glial_cell | 1.00904336 |
| 92 | MP0005423_abnormal_somatic_nervous | 1.00070324 |
| 93 | MP0008874_decreased_physiological_sensi | 0.98861347 |
| 94 | MP0004924_abnormal_behavior | 0.96439212 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.96439212 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.95351212 |
| 97 | MP0004510_myositis | 0.93877516 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.93769124 |
| 99 | MP0001984_abnormal_olfaction | 0.93427595 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 0.92530784 |
| 101 | MP0004885_abnormal_endolymph | 0.92368287 |
| 102 | MP0002067_abnormal_sensory_capabilities | 0.92028131 |
| 103 | * MP0003631_nervous_system_phenotype | 0.91968034 |
| 104 | MP0001849_ear_inflammation | 0.91879256 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.91121415 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.90752907 |
| 107 | MP0003879_abnormal_hair_cell | 0.90669149 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.90225568 |
| 109 | MP0000343_altered_response_to | 0.89556713 |
| 110 | MP0003828_pulmonary_edema | 0.88447319 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.88327183 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.86704114 |
| 113 | * MP0004811_abnormal_neuron_physiology | 0.86544537 |
| 114 | MP0001970_abnormal_pain_threshold | 0.84928675 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.84913304 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.84708206 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.84490137 |
| 118 | MP0002736_abnormal_nociception_after | 0.83788380 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.81961004 |
| 120 | MP0002735_abnormal_chemical_nociception | 0.81022832 |
| 121 | MP0008260_abnormal_autophagy | 0.78600887 |
| 122 | * MP0002066_abnormal_motor_capabilities/c | 0.78223269 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.77332231 |
| 124 | MP0003279_aneurysm | 0.76065991 |
| 125 | MP0003632_abnormal_nervous_system | 0.75847615 |
| 126 | MP0001664_abnormal_digestion | 0.73411441 |
| 127 | MP0000955_abnormal_spinal_cord | 0.68316626 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.68286449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.35618072 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.43340596 |
| 3 | Myoglobinuria (HP:0002913) | 4.26289984 |
| 4 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.25967779 |
| 5 | Sudden death (HP:0001699) | 4.25790315 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.06883531 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.98986429 |
| 8 | Bundle branch block (HP:0011710) | 3.68904876 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 3.54075004 |
| 10 | Myokymia (HP:0002411) | 3.48339029 |
| 11 | Muscle fiber splitting (HP:0003555) | 3.44387562 |
| 12 | Difficulty running (HP:0009046) | 3.36597643 |
| 13 | Scapular winging (HP:0003691) | 3.33452946 |
| 14 | Neck muscle weakness (HP:0000467) | 3.30853138 |
| 15 | Ketoacidosis (HP:0001993) | 3.26255504 |
| 16 | Frequent falls (HP:0002359) | 3.26011859 |
| 17 | Ketosis (HP:0001946) | 3.19381183 |
| 18 | Focal motor seizures (HP:0011153) | 3.14507334 |
| 19 | Ventricular fibrillation (HP:0001663) | 3.12717147 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.11121661 |
| 21 | Myotonia (HP:0002486) | 3.04928897 |
| 22 | Foot dorsiflexor weakness (HP:0009027) | 3.04606317 |
| 23 | Spinal rigidity (HP:0003306) | 3.00273254 |
| 24 | Gout (HP:0001997) | 2.92763785 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 2.91507202 |
| 26 | Abnormality of the foot musculature (HP:0001436) | 2.91052657 |
| 27 | Heart block (HP:0012722) | 2.90795510 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.89202028 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 2.85651472 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 2.85171541 |
| 31 | Muscle stiffness (HP:0003552) | 2.83019820 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 2.80450643 |
| 33 | Rimmed vacuoles (HP:0003805) | 2.80385524 |
| 34 | Atonic seizures (HP:0010819) | 2.79432978 |
| 35 | Visual hallucinations (HP:0002367) | 2.79341044 |
| 36 | Atrioventricular block (HP:0001678) | 2.75087285 |
| 37 | Ventricular tachycardia (HP:0004756) | 2.74488571 |
| 38 | Atrial fibrillation (HP:0005110) | 2.70634152 |
| 39 | Rhabdomyolysis (HP:0003201) | 2.68217092 |
| 40 | Abnormal atrioventricular conduction (HP:0005150) | 2.67575346 |
| 41 | Syncope (HP:0001279) | 2.67560825 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.67118514 |
| 43 | Round ear (HP:0100830) | 2.66778006 |
| 44 | Bulbar palsy (HP:0001283) | 2.66698103 |
| 45 | Hyperglycinuria (HP:0003108) | 2.63193960 |
| 46 | Hyperammonemia (HP:0001987) | 2.61851788 |
| 47 | Prolonged QT interval (HP:0001657) | 2.59198915 |
| 48 | Primary atrial arrhythmia (HP:0001692) | 2.56830588 |
| 49 | Obstructive sleep apnea (HP:0002870) | 2.55707527 |
| 50 | Diplopia (HP:0000651) | 2.55374264 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.55374264 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.54256216 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.52737148 |
| 54 | Dysmetric saccades (HP:0000641) | 2.47296534 |
| 55 | Ventricular arrhythmia (HP:0004308) | 2.46838653 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44744980 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.44744980 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.44419611 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44402523 |
| 60 | Pheochromocytoma (HP:0002666) | 2.43241920 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.43181358 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.43030946 |
| 63 | Subaortic stenosis (HP:0001682) | 2.43030946 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.42656945 |
| 65 | Xanthomatosis (HP:0000991) | 2.42532250 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.42452560 |
| 67 | Lower limb amyotrophy (HP:0007210) | 2.42362245 |
| 68 | Palpitations (HP:0001962) | 2.41113016 |
| 69 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.40008006 |
| 70 | Increased connective tissue (HP:0009025) | 2.39894457 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.39826295 |
| 72 | Supraventricular arrhythmia (HP:0005115) | 2.36798705 |
| 73 | Action tremor (HP:0002345) | 2.32114630 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.31661447 |
| 75 | Cholelithiasis (HP:0001081) | 2.30612959 |
| 76 | Focal seizures (HP:0007359) | 2.28852931 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.26619920 |
| 78 | Nemaline bodies (HP:0003798) | 2.25253955 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22686831 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.19491138 |
| 81 | Febrile seizures (HP:0002373) | 2.19356389 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19269800 |
| 83 | Impaired social interactions (HP:0000735) | 2.16657278 |
| 84 | Abnormal social behavior (HP:0012433) | 2.16657278 |
| 85 | Abnormal EKG (HP:0003115) | 2.16050280 |
| 86 | Axonal loss (HP:0003447) | 2.15557336 |
| 87 | Difficulty climbing stairs (HP:0003551) | 2.15220381 |
| 88 | Hyperglycinemia (HP:0002154) | 2.15210306 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.13547978 |
| 90 | Fetal akinesia sequence (HP:0001989) | 2.13116884 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.11462007 |
| 92 | Lipoatrophy (HP:0100578) | 2.11164035 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.08239612 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 2.07508427 |
| 95 | Ankle clonus (HP:0011448) | 2.06160159 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 2.04518668 |
| 97 | Poor eye contact (HP:0000817) | 2.04198429 |
| 98 | Distal arthrogryposis (HP:0005684) | 2.01623211 |
| 99 | Generalized tonic-clonic seizures (HP:0002069) | 2.01217567 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00775410 |
| 101 | Dilated cardiomyopathy (HP:0001644) | 2.00534228 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99662068 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 1.99662068 |
| 104 | Generalized muscle weakness (HP:0003324) | 1.97719973 |
| 105 | Hyperuricemia (HP:0002149) | 1.96019927 |
| 106 | Increased purine levels (HP:0004368) | 1.96019927 |
| 107 | Weak cry (HP:0001612) | 1.94907665 |
| 108 | Dysdiadochokinesis (HP:0002075) | 1.94483664 |
| 109 | Achilles tendon contracture (HP:0001771) | 1.92293479 |
| 110 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.91276753 |
| 111 | Muscular dystrophy (HP:0003560) | 1.90966393 |
| 112 | Supranuclear gaze palsy (HP:0000605) | 1.90216073 |
| 113 | Abnormality of the lower motor neuron (HP:0002366) | 1.90055325 |
| 114 | Areflexia of lower limbs (HP:0002522) | 1.89825379 |
| 115 | Myopathic facies (HP:0002058) | 1.89754595 |
| 116 | Nonprogressive disorder (HP:0003680) | 1.87304073 |
| 117 | Proximal amyotrophy (HP:0007126) | 1.87178534 |
| 118 | EMG: neuropathic changes (HP:0003445) | 1.86860834 |
| 119 | Rapidly progressive (HP:0003678) | 1.86589274 |
| 120 | Absence seizures (HP:0002121) | 1.86408873 |
| 121 | Dysmetria (HP:0001310) | 1.86298267 |
| 122 | Neonatal onset (HP:0003623) | 1.86149746 |
| 123 | Truncal ataxia (HP:0002078) | 1.85906376 |
| 124 | Metabolic acidosis (HP:0001942) | 1.85130564 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 1.83972714 |
| 126 | Cholecystitis (HP:0001082) | 1.83972714 |
| 127 | Steppage gait (HP:0003376) | 1.83089109 |
| 128 | Torticollis (HP:0000473) | 1.82785815 |
| 129 | Intrahepatic cholestasis (HP:0001406) | 1.81443079 |
| 130 | Status epilepticus (HP:0002133) | 1.81063799 |
| 131 | Abnormal eating behavior (HP:0100738) | 1.80342996 |
| 132 | Central scotoma (HP:0000603) | 1.78503233 |
| 133 | Gowers sign (HP:0003391) | 1.78486404 |
| 134 | * Anxiety (HP:0000739) | 1.77786008 |
| 135 | Limb-girdle muscle atrophy (HP:0003797) | 1.76115480 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.75441498 |
| 137 | Abnormality of purine metabolism (HP:0004352) | 1.75174106 |
| 138 | Slender build (HP:0001533) | 1.74828556 |
| 139 | Malignant hyperthermia (HP:0002047) | 1.74625744 |
| 140 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72187748 |
| 141 | Aortic aneurysm (HP:0004942) | 1.71862590 |
| 142 | Spastic gait (HP:0002064) | 1.70580392 |
| 143 | Lower limb muscle weakness (HP:0007340) | 1.69475922 |
| 144 | * Rigidity (HP:0002063) | 1.69189132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 3.06346175 |
| 2 | PHKG1 | 3.06346175 |
| 3 | TRIB3 | 2.88121654 |
| 4 | TTN | 2.73392579 |
| 5 | EPHA4 | 2.62448178 |
| 6 | OBSCN | 2.50338847 |
| 7 | LMTK2 | 2.49492936 |
| 8 | BCKDK | 2.47072395 |
| 9 | PDK4 | 2.36186089 |
| 10 | PDK3 | 2.36186089 |
| 11 | PRKD3 | 2.31389393 |
| 12 | MAP3K9 | 2.30023300 |
| 13 | NTRK3 | 2.07953595 |
| 14 | LATS2 | 2.02397871 |
| 15 | DAPK2 | 2.01394205 |
| 16 | KSR2 | 2.00172630 |
| 17 | MAP2K4 | 1.94335557 |
| 18 | PRPF4B | 1.76443071 |
| 19 | MAP3K4 | 1.73863580 |
| 20 | PKN2 | 1.69573067 |
| 21 | STK38 | 1.69360922 |
| 22 | PAK6 | 1.65322373 |
| 23 | NEK1 | 1.65107164 |
| 24 | CAMKK1 | 1.60761125 |
| 25 | RIPK1 | 1.55040751 |
| 26 | MARK3 | 1.50314957 |
| 27 | MAP3K7 | 1.47538918 |
| 28 | MINK1 | 1.45051083 |
| 29 | DMPK | 1.39888141 |
| 30 | PDK2 | 1.39663379 |
| 31 | NTRK1 | 1.31069197 |
| 32 | MOS | 1.16203567 |
| 33 | TAOK1 | 1.13291053 |
| 34 | WNK4 | 1.11666874 |
| 35 | PRKCH | 1.08126498 |
| 36 | MAP3K11 | 1.05703429 |
| 37 | PDPK1 | 1.03024012 |
| 38 | EEF2K | 1.02649402 |
| 39 | RET | 1.01362518 |
| 40 | MUSK | 1.00271262 |
| 41 | SGK3 | 0.99588127 |
| 42 | MAPK12 | 0.98928379 |
| 43 | SGK494 | 0.98048659 |
| 44 | SGK223 | 0.98048659 |
| 45 | MAP3K2 | 0.97737178 |
| 46 | MARK1 | 0.95927553 |
| 47 | PDK1 | 0.95779232 |
| 48 | NTRK2 | 0.95565589 |
| 49 | MYLK | 0.95266761 |
| 50 | MAP3K3 | 0.94466582 |
| 51 | PAK3 | 0.93068572 |
| 52 | PRKG2 | 0.92162282 |
| 53 | CDK5 | 0.91624957 |
| 54 | WNK1 | 0.91347563 |
| 55 | CAMK2B | 0.90555372 |
| 56 | CAMK1 | 0.88340243 |
| 57 | MAP2K7 | 0.88101537 |
| 58 | MAP3K1 | 0.86756220 |
| 59 | SIK1 | 0.85867360 |
| 60 | GRK5 | 0.83834999 |
| 61 | TYRO3 | 0.83780040 |
| 62 | PRKD1 | 0.81254652 |
| 63 | PRKAA1 | 0.76387996 |
| 64 | CAMKK2 | 0.76254538 |
| 65 | BRAF | 0.74072357 |
| 66 | STK11 | 0.73840135 |
| 67 | TIE1 | 0.73309136 |
| 68 | ARAF | 0.72340151 |
| 69 | SGK2 | 0.71857499 |
| 70 | CAMK4 | 0.71484070 |
| 71 | CAMK2G | 0.71116663 |
| 72 | MAP3K13 | 0.71049124 |
| 73 | PTK2B | 0.70878618 |
| 74 | CAMK1G | 0.70458125 |
| 75 | KSR1 | 0.69282034 |
| 76 | PKN1 | 0.69027354 |
| 77 | ROCK2 | 0.68685660 |
| 78 | RIPK4 | 0.68001279 |
| 79 | CAMK2D | 0.67248899 |
| 80 | PDGFRA | 0.66467729 |
| 81 | RPS6KA2 | 0.66308862 |
| 82 | CAMK2A | 0.65344152 |
| 83 | INSRR | 0.64834218 |
| 84 | PRKCG | 0.63146389 |
| 85 | PIK3CA | 0.63045326 |
| 86 | CDK14 | 0.60858204 |
| 87 | PRKAA2 | 0.60031670 |
| 88 | FGFR4 | 0.59335119 |
| 89 | UHMK1 | 0.59165161 |
| 90 | LIMK1 | 0.58740427 |
| 91 | ERN1 | 0.58182738 |
| 92 | NME1 | 0.57231275 |
| 93 | TESK1 | 0.56986963 |
| 94 | TAOK2 | 0.56953346 |
| 95 | OXSR1 | 0.56800350 |
| 96 | SGK1 | 0.56736793 |
| 97 | ICK | 0.56720865 |
| 98 | MAP2K3 | 0.55514595 |
| 99 | EPHB1 | 0.55302634 |
| 100 | DAPK3 | 0.54255804 |
| 101 | MAP2K1 | 0.54058898 |
| 102 | MAP2K6 | 0.53994761 |
| 103 | AKT2 | 0.53925359 |
| 104 | CCNB1 | 0.53295695 |
| 105 | DAPK1 | 0.53140883 |
| 106 | IRAK2 | 0.53138382 |
| 107 | LATS1 | 0.52555568 |
| 108 | FGFR2 | 0.51105674 |
| 109 | PRKACG | 0.50768266 |
| 110 | CDK19 | 0.50610846 |
| 111 | PIK3CG | 0.50506560 |
| 112 | ROCK1 | 0.48499333 |
| 113 | MAP3K12 | 0.47955907 |
| 114 | MAP3K5 | 0.47627389 |
| 115 | RPS6KA3 | 0.47510527 |
| 116 | SIK2 | 0.47447191 |
| 117 | JAK2 | 0.46156027 |
| 118 | MAPK10 | 0.45590124 |
| 119 | PTK6 | 0.45570453 |
| 120 | CDC42BPA | 0.45355508 |
| 121 | TNK2 | 0.44488812 |
| 122 | MARK2 | 0.43512958 |
| 123 | MAPKAPK3 | 0.43064058 |
| 124 | PRKD2 | 0.42909276 |
| 125 | CDK15 | 0.42815072 |
| 126 | CAMK1D | 0.42611849 |
| 127 | PRKCZ | 0.41955843 |
| 128 | MAP3K6 | 0.41534044 |
| 129 | PRKG1 | 0.41359479 |
| 130 | RPS6KB1 | 0.40612420 |
| 131 | RAF1 | 0.39982970 |
| 132 | MAPK4 | 0.39842181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46915461 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08114629 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.79849506 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.60456279 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33477211 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22411917 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12781005 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00083661 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94411542 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90607764 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80331556 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80277727 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77877230 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.63840915 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48246409 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45621024 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44509841 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42131409 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40576996 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40422374 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.39393167 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.34930078 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32915145 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32366293 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.29144154 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26697574 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24662292 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19506190 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18321353 |
| 30 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.15097479 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14283103 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12342351 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.11552621 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08238008 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.04548254 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.04303815 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04112817 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01796430 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00604003 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98707537 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98677434 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 0.98273647 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 0.97372372 |
| 44 | Glioma_Homo sapiens_hsa05214 | 0.96803084 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.95827135 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95743731 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94549195 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94263804 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 0.93853728 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93464598 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93218728 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.93072343 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92522494 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90986120 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90824120 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89718735 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86399275 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85575924 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.82637793 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82090717 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79546640 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79084744 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78582779 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77963288 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.77945432 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.76485128 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73897149 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73412622 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72991415 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72843664 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71555080 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70105949 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69716723 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69332897 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68480047 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68425838 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67905553 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67880486 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66603193 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66473280 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65550693 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63397074 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.60870003 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59684731 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58793948 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58612095 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57461763 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56211916 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56165418 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55719121 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.55647641 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.55535136 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.55273483 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54716920 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.54466974 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53542065 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52405753 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52153021 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52133025 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51799403 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51468025 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50589942 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50433386 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49556521 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49257122 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49188198 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48923763 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48831899 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48821716 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.48490610 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.48154136 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46007665 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.45678825 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45255972 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44480519 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43947685 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43432448 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43189162 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43126099 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42017780 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41819153 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.41640479 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41367393 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.41097703 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40861128 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40125419 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39970322 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39887335 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39713508 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39266584 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38733620 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38340214 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38121464 |

